NADINE CAUSEY: Open Payments
NPI 1760253991 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 21 payments from 9 companies in 2025. Trend: 2023 $29 · 2024 $179 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $185 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| ABBVIE INC. | 3 | $72 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Janssen Scientific Affairs, LLC | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: SPRAVATO, Auvelity, VRAYLAR, INGREZZA, CAPLYTA, FANAPT, AUSTEDO XR, REXULTI.
Industry payments across FL — which companies pay providers there.
